ORAL-CONTRACEPTIVES AND PREMENOPAUSAL BREAST-CANCER IN NULLIPAROUS WOMEN

被引：49

作者：

STADEL, BV ^{[1
]}

LAI, SH ^{[1
]}

SCHLESSELMAN, JJ ^{[1
]}

MURRAY, P ^{[1
]}

机构：

[1] UNIFORMED SERV UNIV HLTH SCI,DEPT PREVENT MED & BIOMETR,BETHESDA,MD 20814

来源：

CONTRACEPTION | 1988年 / 38卷 / 03期

关键词：

D O I：

10.1016/0010-7824(88)90101-1

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：287 / 299

页数：13

共 16 条

[1]

[Anonymous], COMMUNICATION

[2] EARLY ORAL-CONTRACEPTIVE USE AND BREAST-CANCER - RESULTS OF ANOTHER CASE-CONTROL STUDY [J].

MCPHERSON, K ;

VESSEY, MP ;

NEIL, A ;

DOLL, R ;

JONES, L ;

ROBERTS, M .

BRITISH JOURNAL OF CANCER, 1987, 56 (05) :653-660

[3]

MEIRIK O, 1986, LANCET, V2, P650

[4]

MEIRIK O, COMMUNICATION

[5]

MILLER DR, 1986, OBSTET GYNECOL, V68, P863

[6]

OLSSON H, 1985, LANCET, V1, P748

[7] CHARACTERISTICS THAT PREDICT RISK OF BREAST-CANCER BEFORE AND AFTER THE MENOPAUSE [J].

PAFFENBARGER, RS ;

KAMPERT, JB ;

CHANG, HG .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 1980, 112 (02) :258-268

[8] ORAL-CONTRACEPTIVES AND BREAST-CANCER - A NATIONAL STUDY [J].

PAUL, C ;

SKEGG, DCG ;

SPEARS, GFS ;

KALDOR, JM .

BRITISH MEDICAL JOURNAL, 1986, 293 (6549) :723-726

[9]

PIKE MC, 1983, LANCET, V2, P926

[10]

SATTIN R W, 1986, New England Journal of Medicine, V315, P405

← 1 2 →